Trials / Terminated
TerminatedNCT05428215
Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients
Comparison of Pharmacokinetics of 17-Beta-Estradiol Via Oral Administration With Sublingual Placement Versus Oral Administration With Swallowing of 17-Beta-estradiol in Male-to-Female Transgender Patients
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- MaineHealth · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This crossover study will investigate the pharmacokinetics of oral versus sublingual administration of 17-beta-estradiol in the trans-female population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 17beta Estradiol | Subjects will take individualized therapeutic dose of 17-beta-estradiol via sublingual and oral administration |
Timeline
- Start date
- 2022-12-29
- Primary completion
- 2023-07-20
- Completion
- 2023-07-20
- First posted
- 2022-06-23
- Last updated
- 2023-07-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05428215. Inclusion in this directory is not an endorsement.